Skip to main content
Caplight Logo









Medherant Limited

Medherant Limited

Private
CoventryHealthcare & Life Scienceshttps://www.medherant.co.uk/

Last Round

Series A

Apr 3, 2023

Total Funding Raised

$6.37M

Company Overview

Medherant Limited is a pharmaceutical company that develops innovative transdermal drug delivery therapies using its proprietary TEPI Patch® technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

transdermal drug deliverydrug-in-adhesiveTEPI Patchdrug delivery platformtransdermal patchcontract formulationpermeation assaydrug delivery technologypharmaceutical developmentpressure-sensitive adhesiveFranz celldrug delivery systemDDSclinical-stage pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medherant Limited Comparables

Compare Medherant Limited with similar companies based on industry and business-model similarity.

Medherant Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProSolus Inc.
80%
Anodyne Nanotech
78%
DifGen Pharmaceuticals
75%

Medherant Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 3, 2023
VC RoundMay 21, 2019
VC RoundDec 11, 2017
SeedSep 27, 2016
SeedMay 6, 2016
Seed
Jun 5, 2015

Key People

Founding team and executive leadership

John Burt

Chief Executive Officer

Executive Team

David Luther

Interim Chief Financial Officer

Executive Team

Medherant Limited Investors

Notable investors and investment history

Medherant Limited investors
InvestorRounds
Mercia Asset ManagementSeed, VC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 544% MoM, reaching 1.8K.

  • Apr 3, 2023

    $4M round led by Mercia Asset Management.

Medherant Limited Filings

Explore SEC and related filing metadata, where available.

Medherant Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medherant Limited's valuation, stock price, and market status.

Is Medherant Limited a public or private company?

Medherant Limited is a private company.

What is the current stock price of Medherant Limited?

Medherant Limited is a private company with no public stock price. No recent secondary market data is available.

How much is Medherant Limited worth (valuation)?

Valuation information for Medherant Limited is not publicly available.

Can I buy Medherant Limited stock?

Medherant Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medherant Limited's last funding round?

Medherant Limited's most recent funding round was Series A on April 3, 2023.

Who are the main investors in Medherant Limited?

Key investors in Medherant Limited include Mercia Asset Management.

Will Medherant Limited IPO soon?

No public IPO plans have been announced for Medherant Limited.

How can I track Medherant Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medherant Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCoventry
Employee Range13
Year Founded2015
Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?